Cargando...
Status of group B streptococcal vaccine development
Streptococcus agalactiae (group B streptococcus, GBS) is a leading causal organism of neonatal invasive diseases and severe infections in the elderly. Despite significant advances in the diagnosis and treatment of GBS infections and improvement in personal hygiene standards, this pathogen is still a...
Gardado en:
| Publicado en: | Clin Exp Vaccine Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Korean Vaccine Society
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795048/ https://ncbi.nlm.nih.gov/pubmed/29399583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7774/cevr.2018.7.1.76 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|